IBDEI1KD ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,26145,1,4,0)
 ;;=4^B18.8
 ;;^UTILITY(U,$J,358.3,26145,2)
 ;;=^5000549
 ;;^UTILITY(U,$J,358.3,26146,0)
 ;;=B18.9^^127^1272^39
 ;;^UTILITY(U,$J,358.3,26146,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26146,1,3,0)
 ;;=3^Chronic Viral Hepatitis,Unspec
 ;;^UTILITY(U,$J,358.3,26146,1,4,0)
 ;;=4^B18.9
 ;;^UTILITY(U,$J,358.3,26146,2)
 ;;=^5000550
 ;;^UTILITY(U,$J,358.3,26147,0)
 ;;=B97.89^^127^1272^106
 ;;^UTILITY(U,$J,358.3,26147,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26147,1,3,0)
 ;;=3^Viral Agents in Disease Classified Elsewhere NEC
 ;;^UTILITY(U,$J,358.3,26147,1,4,0)
 ;;=4^B97.89
 ;;^UTILITY(U,$J,358.3,26147,2)
 ;;=^5000879
 ;;^UTILITY(U,$J,358.3,26148,0)
 ;;=A69.20^^127^1272^75
 ;;^UTILITY(U,$J,358.3,26148,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26148,1,3,0)
 ;;=3^Lyme Disease,Unspec
 ;;^UTILITY(U,$J,358.3,26148,1,4,0)
 ;;=4^A69.20
 ;;^UTILITY(U,$J,358.3,26148,2)
 ;;=^5000375
 ;;^UTILITY(U,$J,358.3,26149,0)
 ;;=A51.0^^127^1272^56
 ;;^UTILITY(U,$J,358.3,26149,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26149,1,3,0)
 ;;=3^Genital Syphilis,Primary
 ;;^UTILITY(U,$J,358.3,26149,1,4,0)
 ;;=4^A51.0
 ;;^UTILITY(U,$J,358.3,26149,2)
 ;;=^5000272
 ;;^UTILITY(U,$J,358.3,26150,0)
 ;;=A52.3^^127^1272^78
 ;;^UTILITY(U,$J,358.3,26150,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26150,1,3,0)
 ;;=3^Neurosyphilis,Unspec
 ;;^UTILITY(U,$J,358.3,26150,1,4,0)
 ;;=4^A52.3
 ;;^UTILITY(U,$J,358.3,26150,2)
 ;;=^5000298
 ;;^UTILITY(U,$J,358.3,26151,0)
 ;;=A52.9^^127^1272^74
 ;;^UTILITY(U,$J,358.3,26151,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26151,1,3,0)
 ;;=3^Late Syphilis,Unspec
 ;;^UTILITY(U,$J,358.3,26151,1,4,0)
 ;;=4^A52.9
 ;;^UTILITY(U,$J,358.3,26151,2)
 ;;=^5000308
 ;;^UTILITY(U,$J,358.3,26152,0)
 ;;=A53.9^^127^1272^98
 ;;^UTILITY(U,$J,358.3,26152,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26152,1,3,0)
 ;;=3^Syphilis,Unspec
 ;;^UTILITY(U,$J,358.3,26152,1,4,0)
 ;;=4^A53.9
 ;;^UTILITY(U,$J,358.3,26152,2)
 ;;=^5000310
 ;;^UTILITY(U,$J,358.3,26153,0)
 ;;=A54.00^^127^1272^57
 ;;^UTILITY(U,$J,358.3,26153,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26153,1,3,0)
 ;;=3^Gonococcal Infection of Lower Genitourinary Tract,Unspec
 ;;^UTILITY(U,$J,358.3,26153,1,4,0)
 ;;=4^A54.00
 ;;^UTILITY(U,$J,358.3,26153,2)
 ;;=^5000311
 ;;^UTILITY(U,$J,358.3,26154,0)
 ;;=B35.1^^127^1272^99
 ;;^UTILITY(U,$J,358.3,26154,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26154,1,3,0)
 ;;=3^Tinea Unguium
 ;;^UTILITY(U,$J,358.3,26154,1,4,0)
 ;;=4^B35.1
 ;;^UTILITY(U,$J,358.3,26154,2)
 ;;=^119748
 ;;^UTILITY(U,$J,358.3,26155,0)
 ;;=B37.3^^127^1272^15
 ;;^UTILITY(U,$J,358.3,26155,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26155,1,3,0)
 ;;=3^Candidiasis of Vulva/Vagina
 ;;^UTILITY(U,$J,358.3,26155,1,4,0)
 ;;=4^B37.3
 ;;^UTILITY(U,$J,358.3,26155,2)
 ;;=^5000615
 ;;^UTILITY(U,$J,358.3,26156,0)
 ;;=B58.9^^127^1272^100
 ;;^UTILITY(U,$J,358.3,26156,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26156,1,3,0)
 ;;=3^Toxoplasmosis,Unspec
 ;;^UTILITY(U,$J,358.3,26156,1,4,0)
 ;;=4^B58.9
 ;;^UTILITY(U,$J,358.3,26156,2)
 ;;=^5000733
 ;;^UTILITY(U,$J,358.3,26157,0)
 ;;=A59.01^^127^1272^102
 ;;^UTILITY(U,$J,358.3,26157,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26157,1,3,0)
 ;;=3^Trichomonal Vulvovaginitis
 ;;^UTILITY(U,$J,358.3,26157,1,4,0)
 ;;=4^A59.01
 ;;^UTILITY(U,$J,358.3,26157,2)
 ;;=^121763
 ;;^UTILITY(U,$J,358.3,26158,0)
 ;;=A59.03^^127^1272^101
 ;;^UTILITY(U,$J,358.3,26158,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26158,1,3,0)
 ;;=3^Trichomonal Cystitis/Urethriti
 ;;^UTILITY(U,$J,358.3,26158,1,4,0)
 ;;=4^A59.03
 ;;^UTILITY(U,$J,358.3,26158,2)
 ;;=^5000349
